Institute of Biomedical Research Corp
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental … Read more
Institute of Biomedical Research Corp (MRES) - Total Liabilities
Latest total liabilities as of March 2025: $775.72K USD
Based on the latest financial reports, Institute of Biomedical Research Corp (MRES) has total liabilities worth $775.72K USD as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Institute of Biomedical Research Corp - Total Liabilities Trend (2004–2025)
This chart illustrates how Institute of Biomedical Research Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Institute of Biomedical Research Corp Competitors by Total Liabilities
The table below lists competitors of Institute of Biomedical Research Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Anglo Philippine Holdings Corp
PSE:APO
|
Philippines | ₱3.76 Billion |
|
SURNF
OTCQB:SURNF
|
USA | $34.16K |
|
Apollomics Inc. Warrant
NASDAQ:APLMW
|
USA | $13.77 Million |
|
Synergia Energy Ltd.
LSE:SYN
|
UK | GBX2.36 Million |
|
DIH Holdings US, Inc. Class A Common Stock
NASDAQ:DHAI
|
USA | $63.89 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Institute of Biomedical Research Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Institute of Biomedical Research Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Institute of Biomedical Research Corp (2004–2025)
The table below shows the annual total liabilities of Institute of Biomedical Research Corp from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $775.72K | -17.06% |
| 2024-03-31 | $935.31K | +23.20% |
| 2023-03-31 | $759.15K | -81.82% |
| 2015-03-31 | $4.18 Million | +6.88% |
| 2014-03-31 | $3.91 Million | +185.16% |
| 2013-03-31 | $1.37 Million | +225.07% |
| 2010-03-31 | $421.57K | +182.13% |
| 2009-03-31 | $149.42K | -19.84% |
| 2008-03-31 | $186.40K | +759.78% |
| 2007-03-31 | $21.68K | -90.46% |
| 2006-03-31 | $227.21K | +149.66% |
| 2005-03-31 | $91.01K | +37.86% |
| 2004-03-31 | $66.01K | -- |